Search results for "AAV; adeno-associated virus; proces…"

Article Top Challenges to Overcome When Developing AAV Processes: Part 1 of 2
AAVprocessdevelopment Click here to view more Industry Leader Q&As >>  In the first of a two-part series, Anki Magnusson, Staff Research Engineer, Protein and Viral Producti…

Article Insights and Strategies for Successful Development of Scalable AAV Processes: Part 2 of 2
part2 Click here to view more Industry Leader Q&As >> In the second of a two-part series, Anki Magnusson, Staff Research Engineer, Protein and Viral Production, and Åsa Hagner…

Article Top Challenges to Overcome When Developing AAV Processes: Part 1 of 2
Watch the Q&A interview >> In the first of a two-part series, Anki Magnusson, Staff Research Engineer, Protein and Viral Production, and Åsa Hagner-McWhirter, PhD, Senior Scientist…

Article Successful Development of Scalable AAV Processes: Part 2 of 2
Watch the Q&A interview >> In the second of a two-part series, Anki Magnusson, Staff Research Engineer, Protein and Viral Production, and Åsa Hagner-McWhirter, PhD, Senior Scientist, Bio…

Article Single-Use Technologies Prove Effective for Viral Vector Process Development
The benefits of single-use technologies for upstream viral-vector processes clearly outweigh their disadvantages. Cynthia A. Challener  Upstream viral-vector processes can have sig…

Article Technology Innovations Improve Process Chromatography Performance
As technology matures, inefficiencies and process limitations in downstream process chromatography are improved. By Feliza Mirasol Selecting an appropriate separation technology fo…

Article Gene Therapies Push Viral Vector Production
Gene Therapies Push Viral Vector Production Viral vectors show promise as a delivery mechanism for gene therapy, but which virus types are commercially viable? By Feliza Miraso…

Article Scaling Up Novel Therapies
Scaling Up Novel Therapies Platform processes have improved monoclonal antibody scale-up. Can they do the same for personalized therapies? By Agnes S…

Article The Challenge of Disruptive Technologies in Bioprocessing
The Challenge of Disruptive Technologies in BioprocessingIncreasing demand for biologics is driving the need for innovation in bioprocessing. Jul 01, 2018 Increasing demand for biologics is drivin…

Article Flexible Facilities for Viral Vector Manufacturing
Single-use and modular systems will meet demand for rapid implementation at different scales.  By Jennifer Markarian Industry experts have noted that there are limitations in the…